ROTASURE DROPS

Rotasure Rotavirus Drops

Rotasure is an oral vaccine used to protect infants and young children against rotavirus infections, which are a leading cause of severe diarrhea and dehydration. Rotavirus can lead to hospitalization and, in severe cases, death, making vaccination a critical step in safeguarding children's health.

How It Works

Rotasure contains a live, attenuated strain of the rotavirus. This weakened virus does not cause the disease but helps the immune system develop protection against future infections. Once vaccinated, the child’s immune system is better prepared to fight off rotavirus if exposed.

Administration

• Dosage: Rotasure is given in a series of oral doses.
• Schedule:
  • Typically administered at 6 weeks, 10 weeks, and 14 weeks of age.
  • Alternatively, it can be given at 2 and 4 months of age, depending on the vaccination schedule.
• Administration Method: Given orally as drops, making it easy to administer to infants.

Side Effects

Common side effects may include:

• Mild diarrhea
• Irritability
• Fever

Severe reactions are rare, but parents should monitor their child for any unusual symptoms and consult a healthcare provider if needed.

Pregnancy and Lactation

• Pregnancy: Not applicable, as Rotasure is intended for infants.
• Lactation: Safe for breastfeeding mothers to administer to their infants.

Age Group

• Minimum Age: Approved for use in infants starting at 6 weeks old.
• Upper Age Limit: The vaccine is typically not given after 24 weeks of age.

Contraindications

• Allergic Reactions: Not recommended for infants with severe allergies to any component of the vaccine.
• Severe Combined Immunodeficiency (SCID): Should not be given to infants with SCID.
• History of Intussusception: Not recommended for infants with a history of intussusception, a condition where part of the intestine folds into another section, causing a blockage.

Nature of Antigen

• Nature of Antigen: Rotasure contains a live, attenuated human strain of rotavirus.Rotasure contains a **live, attenuated human strain** of the rotavirus. Specifically, it includes the **G1P[8] strain** of the rotavirus, which is one of the most common and globally prevalent strains responsible for rotavirus infections in children. The live, attenuated nature of the virus in the vaccine helps the immune system develop immunity without causing the disease.

Vaccine Type

• Type: Rotasure is a monovalent vaccine, meaning it targets a single strain of rotavirus.

Origin and Manufacturer

• Origin: Rotasure is an Indian vaccine.
• Manufacturer: The vaccine is produced by the Serum Institute of India, one of the world's leading vaccine manufacturers.
• Introduction Year: Rotasure was introduced in 2011.

Rotasure is an essential vaccine in the fight against rotavirus, helping to prevent severe gastrointestinal disease in infants and young children. Developed by the Serum Institute of India, Rotasure is widely used in immunization programs and is a key tool in reducing the burden of rotavirus-related hospitalizations and deaths. Always consult healthcare providers for personalized vaccination advice and schedules.